Impaired DNase I activity or the presence of anti-NET antibodies that block its access leads to NET persistence, a feature linked to autoimmune conditions such as systemic lupus erythematosus (SLE) [116,117]. This evidence concerns the gene DNASE1L3 and systemic lupus erythematosus.